Like_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":899783372,"tweetId":"899783372","gmtCreate":1628215355196,"gmtModify":1631890990639,"author":{"id":3579994912149905,"idStr":"3579994912149905","authorId":3579994912149905,"authorIdStr":"3579994912149905","name":"Yangli","avatar":"https://static.tigerbbs.com/25439208a5e1956d7369976afd67267e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":56,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like</p></body></html>","htmlText":"<html><head></head><body><p>Like</p></body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/899783372","repostId":2157451943,"repostType":4,"repost":{"id":"2157451943","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628205795,"share":"https://ttm.financial/m/news/2157451943?lang=&edition=full","pubTime":"2021-08-06 07:23","market":"us","language":"en","title":"Toplines After Hours US Market on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2157451943","media":"Tiger Newspress","summary":"U.S. stock index futures were little changed during overnight trading on Thursday, ahead of Friday’s","content":"<p>U.S. stock index futures were little changed during overnight trading on Thursday, ahead of Friday’s highly anticipated jobs report.</p>\n<p>At 7:20&nbsp;p.m. ET, Dow e-minis were down 32 points, or 0.09%, S&amp;P 500 e-minis were down 3.25 points, or 0.07%, and Nasdaq 100 e-minis were down 5.25 points, or 0.03%.<img src=\"https://static.tigerbbs.com/fa2a1e6921f0962bd65e976709b6688d\" tg-width=\"1125\" tg-height=\"410\" referrerpolicy=\"no-referrer\"></p>\n<h3><b>Stocks making the biggest moves after hours:</b></h3>\n<p><a href=\"https://laohu8.com/S/DRNA\">Dicerna Pharmaceuticals</a> 24% LOWER; announced positive top-line results from the Company’s PHYOX™2 pivotal clinical trial of nedosiran, which is in development as a once-monthly treatment for primary hyperoxaluria (PH), a family of ultra-rare, life-threatening genetic disorders that initially manifest with complications in the kidneys. Nedosiran is Dicerna’s lead GalXC™ RNAi therapeutic candidate and is designed to inhibit the hepatic lactate dehydrogenase (LDH) enzyme – an enzyme that catalyzes the final step in the glyoxylate metabolism pathway that can lead to oxalate overproduction in patients with PH. The PHYOX2 clinical trial included participants with PH subtypes 1 and 2 (PH1 and PH2).</p>\n<p><a href=\"https://laohu8.com/S/GRPN\">Groupon</a> 14.8% HIGHER; reported Q2 EPS of $0.33, $0.36 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $266 million versus the consensus estimate of $242.47 million. Groupon sees FY2021 revenue of $950-990 million, versus the consensus of $998.1 million.</p>\n<p><a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> 15.7% LOWER; reported Q2 EPS of $0.02, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $720 million versus the consensus estimate of $713.01 million. Entered into a definitive agreement toacquireStarLark, developer of the fast-growing and second-largest mobile golf game in the world, Golf Rival, from Betta Games for $525 million in cash and stock.</p>\n<p><a href=\"https://laohu8.com/S/CSOD\">Cornerstone OnDemand</a> 13.2% HIGHER; entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. (together with certain of its affiliates, Clearlake), a leading private equity firm. Under the terms of the agreement, Clearlake will acquire the outstanding shares of Cornerstone common stock for $57.50 per share in cash. The transaction has an enterprise value of approximately $5.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/RAMP\">LiveRamp Holdings, Inc.</a> 12.2% HIGHER; reported Q1 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $119 million versus the consensus estimate of $112.03 million.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> 9.5% HIGHER; reported Q2 EPS of $0.26, $0.67 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.34 billion versus the consensus estimate of $2.44 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYNA\">Synaptics</a> 7.2% HIGHER; reported Q4 EPS of $2.18, $0.18 better than the analyst estimate of $2.00. Revenue for the quarter came in at $327.8 million versus the consensus estimate of $324.45 million. Synaptics sees Q1 2022 revenue of $355-385 million, versus the consensus of $349.05 million.</p>\n<p><a href=\"https://laohu8.com/S/NVAX\">Novavax</a> 9% LOWER; Delayed Submission for U.S. Vaccine Approval</p>\n<p><a href=\"https://laohu8.com/S/NET\">Cloudflare, Inc.</a> 5.3% LOWER; reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $152.4 million versus the consensus estimate of $146.06 million. Cloudflare sees FY2021 EPS of ($0.11)-($0.12), versus the consensus of ($0.10). Cloudflare sees FY2021 revenue of $629-633 million, versus the consensus of $614.8 million.</p>\n<p><a href=\"https://laohu8.com/S/EXPE\">Expedia</a> 5.2% LOWER; reported Q2 EPS of ($1.13), $0.48 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2 billion.</p>\n<p><a href=\"https://laohu8.com/S/QDEL\">Quidel</a> 6.9% LOWER; reported Q2 EPS of $0.75, $0.71 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $176.6 million versus the consensus estimate of $194.5 million.</p>\n<p><a href=\"https://laohu8.com/S/SPCE\">Virgin Galactic</a> 5.2% HIGHER; reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $570 thousand versus the consensus estimate of $380 thousand. Reopening Sales, with Prices Beginning at $450,000 Per Seat.</p>\n<p><a href=\"https://laohu8.com/S/PLUG\">Plug Power</a> 7.9% HIGHER; reported Q2 EPS of ($0.18), $0.10 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $124.6 million versus the consensus estimate of $114.02 million.</p>\n<p><a href=\"https://laohu8.com/S/Z\">Zillow</a> 1.14% HIGHER; reported Q2 revenue of $1.3 billion versus the consensus estimate of $1.28 billion.</p>\n<p><a href=\"https://laohu8.com/S/OCUL\">Ocular Therapeutix</a> 4.52% LOWER; announced that Regeneron (NASDAQ:REGN) has terminated the option and license agreement collaboration between the companies. The termination became effective August 5, 2021.</p>\n<p><a href=\"https://laohu8.com/S/MNST\">Monster Beverage</a> 1.69% HIGHER; reported Q2 EPS of $0.75, $0.07 better than the analyst estimate of $0.68. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.39 billion.</p>\n<p><a href=\"https://laohu8.com/S/AIG\">American International Group Inc</a> 2.96% HIGHER; reported Q2 EPS of $1.52, $0.35 better than the analyst estimate of $1.17.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines After Hours US Market on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines After Hours US Market on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-06 07:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures were little changed during overnight trading on Thursday, ahead of Friday’s highly anticipated jobs report.</p>\n<p>At 7:20&nbsp;p.m. ET, Dow e-minis were down 32 points, or 0.09%, S&amp;P 500 e-minis were down 3.25 points, or 0.07%, and Nasdaq 100 e-minis were down 5.25 points, or 0.03%.<img src=\"https://static.tigerbbs.com/fa2a1e6921f0962bd65e976709b6688d\" tg-width=\"1125\" tg-height=\"410\" referrerpolicy=\"no-referrer\"></p>\n<h3><b>Stocks making the biggest moves after hours:</b></h3>\n<p><a href=\"https://laohu8.com/S/DRNA\">Dicerna Pharmaceuticals</a> 24% LOWER; announced positive top-line results from the Company’s PHYOX™2 pivotal clinical trial of nedosiran, which is in development as a once-monthly treatment for primary hyperoxaluria (PH), a family of ultra-rare, life-threatening genetic disorders that initially manifest with complications in the kidneys. Nedosiran is Dicerna’s lead GalXC™ RNAi therapeutic candidate and is designed to inhibit the hepatic lactate dehydrogenase (LDH) enzyme – an enzyme that catalyzes the final step in the glyoxylate metabolism pathway that can lead to oxalate overproduction in patients with PH. The PHYOX2 clinical trial included participants with PH subtypes 1 and 2 (PH1 and PH2).</p>\n<p><a href=\"https://laohu8.com/S/GRPN\">Groupon</a> 14.8% HIGHER; reported Q2 EPS of $0.33, $0.36 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $266 million versus the consensus estimate of $242.47 million. Groupon sees FY2021 revenue of $950-990 million, versus the consensus of $998.1 million.</p>\n<p><a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> 15.7% LOWER; reported Q2 EPS of $0.02, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $720 million versus the consensus estimate of $713.01 million. Entered into a definitive agreement toacquireStarLark, developer of the fast-growing and second-largest mobile golf game in the world, Golf Rival, from Betta Games for $525 million in cash and stock.</p>\n<p><a href=\"https://laohu8.com/S/CSOD\">Cornerstone OnDemand</a> 13.2% HIGHER; entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. (together with certain of its affiliates, Clearlake), a leading private equity firm. Under the terms of the agreement, Clearlake will acquire the outstanding shares of Cornerstone common stock for $57.50 per share in cash. The transaction has an enterprise value of approximately $5.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/RAMP\">LiveRamp Holdings, Inc.</a> 12.2% HIGHER; reported Q1 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $119 million versus the consensus estimate of $112.03 million.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> 9.5% HIGHER; reported Q2 EPS of $0.26, $0.67 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.34 billion versus the consensus estimate of $2.44 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYNA\">Synaptics</a> 7.2% HIGHER; reported Q4 EPS of $2.18, $0.18 better than the analyst estimate of $2.00. Revenue for the quarter came in at $327.8 million versus the consensus estimate of $324.45 million. Synaptics sees Q1 2022 revenue of $355-385 million, versus the consensus of $349.05 million.</p>\n<p><a href=\"https://laohu8.com/S/NVAX\">Novavax</a> 9% LOWER; Delayed Submission for U.S. Vaccine Approval</p>\n<p><a href=\"https://laohu8.com/S/NET\">Cloudflare, Inc.</a> 5.3% LOWER; reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $152.4 million versus the consensus estimate of $146.06 million. Cloudflare sees FY2021 EPS of ($0.11)-($0.12), versus the consensus of ($0.10). Cloudflare sees FY2021 revenue of $629-633 million, versus the consensus of $614.8 million.</p>\n<p><a href=\"https://laohu8.com/S/EXPE\">Expedia</a> 5.2% LOWER; reported Q2 EPS of ($1.13), $0.48 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2 billion.</p>\n<p><a href=\"https://laohu8.com/S/QDEL\">Quidel</a> 6.9% LOWER; reported Q2 EPS of $0.75, $0.71 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $176.6 million versus the consensus estimate of $194.5 million.</p>\n<p><a href=\"https://laohu8.com/S/SPCE\">Virgin Galactic</a> 5.2% HIGHER; reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $570 thousand versus the consensus estimate of $380 thousand. Reopening Sales, with Prices Beginning at $450,000 Per Seat.</p>\n<p><a href=\"https://laohu8.com/S/PLUG\">Plug Power</a> 7.9% HIGHER; reported Q2 EPS of ($0.18), $0.10 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $124.6 million versus the consensus estimate of $114.02 million.</p>\n<p><a href=\"https://laohu8.com/S/Z\">Zillow</a> 1.14% HIGHER; reported Q2 revenue of $1.3 billion versus the consensus estimate of $1.28 billion.</p>\n<p><a href=\"https://laohu8.com/S/OCUL\">Ocular Therapeutix</a> 4.52% LOWER; announced that Regeneron (NASDAQ:REGN) has terminated the option and license agreement collaboration between the companies. The termination became effective August 5, 2021.</p>\n<p><a href=\"https://laohu8.com/S/MNST\">Monster Beverage</a> 1.69% HIGHER; reported Q2 EPS of $0.75, $0.07 better than the analyst estimate of $0.68. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.39 billion.</p>\n<p><a href=\"https://laohu8.com/S/AIG\">American International Group Inc</a> 2.96% HIGHER; reported Q2 EPS of $1.52, $0.35 better than the analyst estimate of $1.17.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CSOD":"Cornerstone OnDemand","ZNGA":"Zynga","AIG":"美国国际集团","RAMP":"LiveRamp Holdings, Inc.","OCUL":"Ocular Therapeutix","SYNA":"Synaptics Incorporated","CVNA":"Carvana Co.","GRPN":"GroupOn","NVAX":"诺瓦瓦克斯医药","DRNA":"Dicerna Pharmaceuticals, Inc.","Z":"Zillow"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157451943","content_text":"U.S. stock index futures were little changed during overnight trading on Thursday, ahead of Friday’s highly anticipated jobs report.\nAt 7:20 p.m. ET, Dow e-minis were down 32 points, or 0.09%, S&P 500 e-minis were down 3.25 points, or 0.07%, and Nasdaq 100 e-minis were down 5.25 points, or 0.03%.\nStocks making the biggest moves after hours:\nDicerna Pharmaceuticals 24% LOWER; announced positive top-line results from the Company’s PHYOX™2 pivotal clinical trial of nedosiran, which is in development as a once-monthly treatment for primary hyperoxaluria (PH), a family of ultra-rare, life-threatening genetic disorders that initially manifest with complications in the kidneys. Nedosiran is Dicerna’s lead GalXC™ RNAi therapeutic candidate and is designed to inhibit the hepatic lactate dehydrogenase (LDH) enzyme – an enzyme that catalyzes the final step in the glyoxylate metabolism pathway that can lead to oxalate overproduction in patients with PH. The PHYOX2 clinical trial included participants with PH subtypes 1 and 2 (PH1 and PH2).\nGroupon 14.8% HIGHER; reported Q2 EPS of $0.33, $0.36 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $266 million versus the consensus estimate of $242.47 million. Groupon sees FY2021 revenue of $950-990 million, versus the consensus of $998.1 million.\nZynga 15.7% LOWER; reported Q2 EPS of $0.02, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $720 million versus the consensus estimate of $713.01 million. Entered into a definitive agreement toacquireStarLark, developer of the fast-growing and second-largest mobile golf game in the world, Golf Rival, from Betta Games for $525 million in cash and stock.\nCornerstone OnDemand 13.2% HIGHER; entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. (together with certain of its affiliates, Clearlake), a leading private equity firm. Under the terms of the agreement, Clearlake will acquire the outstanding shares of Cornerstone common stock for $57.50 per share in cash. The transaction has an enterprise value of approximately $5.2 billion.\nLiveRamp Holdings, Inc. 12.2% HIGHER; reported Q1 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $119 million versus the consensus estimate of $112.03 million.\nCarvana Co. 9.5% HIGHER; reported Q2 EPS of $0.26, $0.67 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.34 billion versus the consensus estimate of $2.44 billion.\nSynaptics 7.2% HIGHER; reported Q4 EPS of $2.18, $0.18 better than the analyst estimate of $2.00. Revenue for the quarter came in at $327.8 million versus the consensus estimate of $324.45 million. Synaptics sees Q1 2022 revenue of $355-385 million, versus the consensus of $349.05 million.\nNovavax 9% LOWER; Delayed Submission for U.S. Vaccine Approval\nCloudflare, Inc. 5.3% LOWER; reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $152.4 million versus the consensus estimate of $146.06 million. Cloudflare sees FY2021 EPS of ($0.11)-($0.12), versus the consensus of ($0.10). Cloudflare sees FY2021 revenue of $629-633 million, versus the consensus of $614.8 million.\nExpedia 5.2% LOWER; reported Q2 EPS of ($1.13), $0.48 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2 billion.\nQuidel 6.9% LOWER; reported Q2 EPS of $0.75, $0.71 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $176.6 million versus the consensus estimate of $194.5 million.\nVirgin Galactic 5.2% HIGHER; reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $570 thousand versus the consensus estimate of $380 thousand. Reopening Sales, with Prices Beginning at $450,000 Per Seat.\nPlug Power 7.9% HIGHER; reported Q2 EPS of ($0.18), $0.10 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $124.6 million versus the consensus estimate of $114.02 million.\nZillow 1.14% HIGHER; reported Q2 revenue of $1.3 billion versus the consensus estimate of $1.28 billion.\nOcular Therapeutix 4.52% LOWER; announced that Regeneron (NASDAQ:REGN) has terminated the option and license agreement collaboration between the companies. The termination became effective August 5, 2021.\nMonster Beverage 1.69% HIGHER; reported Q2 EPS of $0.75, $0.07 better than the analyst estimate of $0.68. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.39 billion.\nAmerican International Group Inc 2.96% HIGHER; reported Q2 EPS of $1.52, $0.35 better than the analyst estimate of $1.17.","news_type":1,"symbols_score_info":{"AIG":0.9,"CSOD":0.9,"CVNA":0.9,"DRNA":0.9,"GRPN":0.9,"NVAX":0.9,"OCUL":0.9,"RAMP":0.9,"SYNA":0.9,"Z":0.9,"ZNGA":0.9}},"isVote":1,"tweetType":1,"viewCount":366,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/899783372"}